Status:
COMPLETED
New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
Lead Sponsor:
Hywel Dda Health Board
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Abertawe Bro Morgannwg University NHS Trust
Conditions:
Obstructive Sleep Apnoea Hypopnoea Syndrome
Biomarkers of Fibrin Clot Structure
Eligibility:
All Genders
18-80 years
Brief Summary
Obstructive Sleep Apnoea Hypopnoea Syndrome(OSAHS)affects at least 4% of males and 2% of females. OSAHS is the combination of excessive daytime sleepiness, snoring and apnoeas (stopping breathing at ...
Detailed Description
Primary objective: The primary outcome of this study is to test the null hypothesis that no significant difference exists between fractal dimension (Df)and vascular injury markers including serum amy...
Eligibility Criteria
Inclusion
- 18-80 year old with h/o daytime sleepiness, snoring and apnoeas
Exclusion
- Refusal to give written informed consent.
- Personal or family history of pro- thrombotic or bleeding disorders, severe liver disease (clotting problems) and those prescribed warfarin or heparin.
- Those with borderline sleep studies (4% Diprate or AHI 10-14 per hour).
- Aged less than 18 years or greater than 80 years.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01525160
Start Date
October 1 2011
End Date
March 1 2013
Last Update
April 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince Philip Hospital
Llanelli, Dafan, United Kingdom, SA14 8QF